A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium

Dietmar Pils, Dan Tong, Gudrun Hager, Eva Obermayr, Stefanie Aust, Georg Heinze, Maria Kohl, Eva Schuster, Andrea Wolf, Jalid Sehouli, Ioana Braicu, Ignace Vergote, Toon Van Gorp, Sven Mahner, Nicole Concin, Paul Speiser, Robert Zeillinger

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageEnglish
Article number178
JournalBMC Cancer
Volume13
DOIs
Publication statusPublished - 3 Apr 2013

Keywords

  • Peripheral blood leukocytes
  • Biomarker
  • Transcriptomics
  • Plasma protein
  • Diagnosis
  • Ovarian cancer

Cite this

Pils, D., Tong, D., Hager, G., Obermayr, E., Aust, S., Heinze, G., Kohl, M., Schuster, E., Wolf, A., Sehouli, J., Braicu, I., Vergote, I., Van Gorp, T., Mahner, S., Concin, N., Speiser, P., & Zeillinger, R. (2013). A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium. BMC Cancer, 13, [178]. https://doi.org/10.1186/1471-2407-13-178